false
0001676047
0001676047
2025-02-01
2025-02-01
0001676047
us-gaap:CommonStockMember
2025-02-01
2025-02-01
0001676047
NTRB:WarrantsMember
2025-02-01
2025-02-01
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
February 1, 2025
Nutriband Inc.
| Nevada |
|
000-40854 |
|
81-1118176 |
(State or Other Jurisdiction
of Incorporation) |
|
(Commission File Number) |
|
(I.R.S. Employer
Identification No.) |
121 S. Orange Ave. Suite 1500
Orlando, Florida |
|
32801 |
| (Address of Principal Executive Offices) |
|
(Zip Code) |
(407) 377-6695
Registrant’s Telephone Number, Including
Area Code
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.
below):
| ☐ | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act.
Securities registered pursuant to Section 12(b)
of the Act:
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Common Stock |
|
NTRB |
|
The Nasdaq Stock Market LLC |
| Warrants |
|
NTRBW |
|
The Nasdaq Stock Market LLC |
Item
7.01. Regulation FD Disclosure.
Recent
Exercises of Outstanding Company Options and Warrants
The following
numbers of outstanding options and warrants of the Company have been exercised in the period February 1 through July 31, 2025: stock options
covering 20,055 shares of common stock for a total exercise price of $44,206; public warrants (NTRBW) to purchase 47,076 shares of common
stock for a total purchase price of $302,699; and warrants to purchase 778,041 shares of common stock exercised by private investors,
for a total exercise price of $5,002,804.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
The following exhibits are being filed with this Current Report on
Form 8-K:
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934,
THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED THEREUNTO DULY AUTHORIZED.
| |
NUTRIBAND, INC. |
| |
|
|
| Date: September 3, 2025 |
By: |
/s/ Serguei Melnik |
| |
|
Serguei Melnik |
| |
|
President |
2
